The next CRISPR fight, cheaper insulin, & an FDA shuffle

And our new segment: "Womp womp of the week"

March 3, 2023 Check out STAT+

Sponsored By

Who invented CRISPR 2.0? What happens when a drug company actually lowers prices? And is Novavax going to survive? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Our colleague Allison DeAngelis joins us to explain how the latest CRISPR breakthrough is shaping up to be a free-for-all among a multitude of companies and labs, including some of the biggest names in biotech. We also discuss the latest news in the life sciences, including Eli Lilly slashing the cost of insulin, succession at the FDA, and how pandemic boom times have turned to bust. Listen Now Subscribe to the podcast to never miss an episode iTunes SoundCloud Stitcher TuneIn Google Play Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser